Unique Medicated Chewing Gum | Enorama Pharma

FOR MORE INFORMATION

A nicotine gum with your own brand?

Learn more about our superior nicotine gum and how it is adapted to fit a market with huge potential.

FOR MORE INFORMATION

FOR MORE INFORMATION

The ChewMed^® platform offers unique possibilities

Realize the benefits of our technology for development of active gums.

FOR MORE INFORMATION

FOR MORE INFORMATION

Let us develop your medicated gum application together

Learn more about how to become a partner and what´s in our pipeline.

FOR MORE INFORMATION

Interested in collaboration?

READ MORE

Enorama Pharma receives approval from the MPA for the nicotine chewing gum

Enorama Pharma has received approval from the Swedish MPA for each of the Company's four nicotine products.

READ MORE

Enorama Pharma's pathway towards a medical cannabis chewing gum

Enorama Pharma believes that there will be a great need for serious cannabis products in the future.

READ MORE

Trump administration strips India of special trade status and preferential market access

This decision does not affect Enorama Pharma's ongoing development work in India.

READ MORE

The Greek market for smoking cessation products is growing and so is the interest in nicotine gum

Enorama Pharma travels to Athens to meet several potential customers.

Enorama Pharma enters into agreement within Cough & Cold

In February 2019, Enorama Pharma entered into an agreement with the company MediiGum LLC.

Enorama Pharma enters into agreement within Cough & Cold

READ MORE

Enorama Pharma establishes a development lab for medicinal cannabis

The Company establishes a development laboratory at Malmö University's Open Lab, Sweden.

Meet us at Nasdaq First North Growth Market